News

When San Francisco’s new flavored tobacco ordinance goes into effect next spring, it will be the strongest law in the country limiting the sale of flavored and menthol tobacco products. While other cities have passed laws reducing access to flavored vaping liquids and flavored tobacco, San Francisco

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses. The method enables scientists to bypass the usual

​ America’s most popular search engine could soon be assisting with cancer research. Google search volume across the United States could help fill in the gaps on cancer incidence and mortality data, according to a new study by scientists at UC San Francisco and the University of Pennsylvania. This

A UC San Francisco cancer researcher has led a team of data scientists and engineers to win a first-of-its-kind Artificial Intelligence (AI) Genomics Hackathon competition. Jyotika ‘Jo’ Varshney, DVM, PhD, a UCSF postdoctoral fellow, and her three teammates were named the winners at the event, which

Postmenopausal patients with "ultralow-risk" breast cancers may be able to forgo standard endocrine treatment with tamoxifen, which is routinely prescribed after surgery for many patients. The new findings come from a long-term follow-up of patients who were retrospectively tested with the

​Youth-rated films, which are designed and marketed as kid-friendly, continue to fill the movie screen with tobacco imagery, according to a new report from UC San Francisco, the U.S. Centers for Disease Control and Prevention, and other entities. Nearly half (46 percent) of the films with smoking

A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UC San Francisco in collaboration with colleagues in Sweden. As a result, “ultralow” risk patients could be